Status:
TERMINATED
3-Month Trial Observation of A1c Change
Lead Sponsor:
Endocrine Research Society
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
Phase:
NA
Brief Summary
The incidence of type 2 diabetes in long term care facilities has been approximated at 25% with barriers to treatment including untimely access to a specialist and improper/poor adherence to insulin r...
Detailed Description
Purpose: This project will investigate the benefits (as measured by change in the primary outcome measure hemoglobin A1c) of bi-weekly reporting of blood sugar values for patients with type 2 diabetes...
Eligibility Criteria
Inclusion
- Type II diabetes mellitus patients at Point Grey Private Hospital
- Trained in self-blood glucose monitoring
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be trained on IBGMS
Exclusion
- Patients with medical conditions that may affect their study participation or results will be excluded.
- Patients currently being treated with steroid medication
- Patients that have impaired liver function
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01415271
Start Date
October 1 2011
End Date
September 1 2012
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endocrine Research Society
Vancouver, British Columbia, Canada, V6E 1M7